E

Eikon Therapeutics

Develops therapies with single-molecule tracking

Director Site Engagement & Monitoring Excellence

Clinical Research OperationsConfirmed live in the last 24 hours
Contract$100.50 - $121 /hr

About the Job

Requirements

  • A postgraduate degree with at least 10 years of experience, or a bachelor's degree with at least 12 years of experience, in a relevant field such as Life Sciences, Nursing, or a related discipline.
  • Significant management experience in an oncology clinical trial setting, including management of budget, resources, headcount, processes and controls, productivity, quality, and project delivery.
  • A complete understanding of ICH Good Clinical Practice and global and regional regulatory requirements.
  • Proficiency in written and spoken English.
  • Strategic thinking and high emotional intelligence.
  • Strong leadership skills to attract, motivate, inspire, develop, and retain talented staff, and to align teams with company goals, purpose, and mission.

Responsibilities

  • Define and implement site engagement strategies to improve relationships.
  • Support the development of new partnerships and networks.
  • Support high-quality monitoring approaches and ensure alignment with regulatory standards.
  • Serve as a liaison between clinical study teams and investigative sites.
  • Provide guidance, oversight, and training to the study site engagement team, including CRA site monitors and insourced or outsourced suppliers.
  • Develop and maintain performance standards, processes, and documentation for harmonized site engagement and monitoring support across clinical programs.
  • Maintain information exchange within the study site engagement team; identify common support elements across regions and countries; codify and apply lessons learned; troubleshoot issues; and distribute site intelligence to Clinical Operations study teams and Clinical Development stakeholders.
  • Oversee resource and talent management of the site engagement team, including CRA monitors and outsourced suppliers, across regional and country clusters.
  • Oversee and train FSPs, study site engagement staff, and CRAs by country and region; identify and manage CRA performance issues; ensure corrective and preventive actions; and meet ICH GCP compliance, regulatory, quality, and timeline objectives for global trials.
  • Use interpretive signals and local country intelligence to proactively identify site and monitoring quality risks; lead site- and country-level risk assessments and determine mitigations and controls; use metrics, site health information, and Risk-Based Monitoring signals to enhance quality and study delivery; and track engagement metrics and satisfaction scores.
  • Share site quality trends and preventive actions across studies and assets in clinical programs.
  • Act as the escalation point for site engagement issues, escalating as needed and keeping Clinical Operations study teams informed of escalations and resolutions; apply judgment concerning regulations, guidelines, investigator interactions, and timelines.
  • Manage the functional budget, resource projections, capacity assessment, and vendor oversight and evaluation to ensure appropriate resourcing for the clinical trial portfolio.
  • Align with global Clinical Development stakeholders on strategies and approaches for clinical programs and studies.
  • Contribute to department infrastructure development, including SOP development, process implementation and innovation, and clinical system capabilities.
  • Collaborate with Clinical Development leadership on projects and monitor industry trends and innovations to apply best practices in study site engagement.
  • Develop, coach, and retain team talent; set performance standards and hold the organization accountable for results using metrics and KPIs.

Desired Qualifications

  • Skills in more than one language are an advantage.
  • Up to 25% travel is expected.

About the Company

Eikon Therapeutics

Develops therapies with single-molecule tracking

Eikon Therapeutics develops medicines by studying living cells with advanced engineering and data science. Its SMT platform visualizes protein motion in real time, while AI and automated workflows analyze these movements to map molecular interactions and identify drug targets. The company blends data science, chemistry, biology, engineering, and clinical expertise to inventory dynamic cellular processes at high scale, rather than relying on static snapshots. Its goal is to create therapies that improve and extend patients’ lives by targeting dynamic protein interactions inside cells.

Company size
201-500
Company stage
IPO
Headquarters
Millbrae, CA
Founded
2019

Recently Posted Jobs

Explore more opportunities at Eikon Therapeutics

See more jobs